Loading
Latest filing published 06 Aug 2026 for Neogenomics INC, €279k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Greg D. Aunan appears in our data through filings on Neogenomics Inc shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 1 May 2024 and the latest from 4 August 2026.
Every open-market trade on record is a sale: 1 sale worth €279k. Other entries cover 4 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
On 6 August 2026 came the latest disclosure, an open-market sale for €279k in Neogenomics Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations